Advanced Meridian Assessment (AMA) by Dr. Simon Yu – Bonn

Summary: Acupuncture/Advanced Meridian Assessment (AMA) by Dr. Simon Yu (St. Louis) is a modernized, digitized advancement of Electroacupuncture according to Voll (EAV). It is used for pattern recognition within acupuncture meridian systems to identify overload/interference fields—including parasites, fungi/mold, heavy metals, and dental disturbance fields. AMA does not replace conventional diagnostics but can help prioritize therapy pathways and monitor progress. Learn more directly from Dr. Yu: preventionandhealing.com

What can AMA screen for?

The method targets pattern recognition at ~40 key acupuncture points and is used in addition to history, clinical exam, and labs/imaging.

What does an AMA session look like?

1. History & goal setting (symptoms, prior conditions, existing findings)
2. Meridian screening using standardized measuring points (digital EAV variant)
3. Interpretation: patterns & suspected axes (e.g., parasitic, dental, mycotic)
4. Validation with clinical findings/labs where meaningful
5. Therapy pathway (prioritized; often sequential: parasites, mycoses, metals, dental)
6. Monitoring (symptom scales, HRV, functional scores; AMA follow-up)

Focus: Antiparasitic therapy (Off-label)—when and why?

A core element in Dr. Yu’s approach is diagnostic and therapeutic testing for parasite-driven interference fields. When the overall constellation (history, clinical picture, AMA patterns and—where appropriate—objective findings) points that way, a time-limited, physician-supervised off-label therapy with antiparasitic agents may be considered. Commonly referenced substances in international literature and experiential medicine (no dosing advice here):

Goals: Reduce potential parasitic load, deactivate interference fields, and improve neuro-immune regulation.

Important: Off-label use = use outside approved indications/regimens—only after thorough informed consent.

Safety: Check interactions (e.g., anticoagulants/antiepileptics), liver enzymes, blood count, pregnancy status, and neuropsychiatric comorbidities.

Evidence base: Heterogeneous; strong guideline-level evidence exists for specific parasitic diseases, whereas evidence for functional symptom clusters is limited. We transparently provide this as an individual therapeutic trial. More on the AMA approach from Dr. Yu: preventionandhealing.com

Complementary therapy axes informed by AMA

These components are applied stepwise and with tolerability first.

How we proceed in our Bonn practice

1. Evaluation: AMA + integration with conventional diagnostics (labs/imaging where indicated)
2. Prioritization: Parasites, fungi, metals, dental (individualized)
3. Therapy: if appropriate, off-label antiparasitics with safety monitoring
4. Monitoring: symptom/functional scores (sleep, pain, energy), HRV, and labs as needed
5. Re-evaluation/booster: adapt based on response pattern

Frequently asked questions (FAQ)

Does AMA replace labs & imaging?
No. AMA provides orienting pattern recognition and is used in addition.

 

How safe are antiparasitics?
When properly indicated and medically supervised, they are generally manageable; contraindications/interactions are carefully assessed.

 

What does informed consent include?
We discuss benefits/risks/alternatives, document off-label use, and agree on a monitoring plan.

 

How fast might results appear?
Often within 2–6 weeks; complex cases may require sequential steps (dental/mycoses/metals).

 

Costs?
Largely self-pay/private; individual reimbursement may be possible.

This post is also available in: Deutsch